Nurse Practitioner · Fort Myers, FL
NPI
1598752586
Since 2005
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
12700 Creekside Ln, Ste 201
Fort Myers, FL, 33919
Phone (239) 600-7808
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
1,868 services
Medicare patients, 2024
169
Average age 74
Drug cost, 2024
$1.7M
4,071 prescriptions
Company payments, 2025
$786
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tammara Bezanson was code 36415 (venipuncture blood collection), 322 times for 154 patients. In total Tammara Bezanson billed 1,868 services in 21 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 322 | 154 | $8.62 | $2,777 |
| 80053 Clinical Chemistry | Office | 215 | 108 | $10.16 | $2,185 |
| 84481 Clinical Chemistry | Office | 189 | 88 | $16.33 | $3,086 |
| 84439 Clinical Chemistry | Office | 187 | 87 | $8.61 | $1,610 |
| 84443 Clinical Chemistry | Office | 184 | 86 | $16.02 | $2,948 |
| 80061 Clinical Chemistry | Office | 164 | 77 | $12.88 | $2,112 |
| 83036 Blood Count | Office | 159 | 76 | $9.29 | $1,476 |
| 82043 Clinical Chemistry | Office | 159 | 76 | $5.52 | $878 |
| 82570 Clinical Chemistry | Office | 159 | 76 | $4.95 | $788 |
| 82306 Clinical Chemistry | Office | 47 | 33 | $29.01 | $1,363 |
| 85025 Blood Count | Office | 23 | 12 | $7.61 | $175 |
| 99214 Office E&M - Established | Office | 22 | 22 | $87.66 | $1,928 |
By year: 2022 $20K for 1,882 services; 2023 $17K for 1,479 services; 2024 $22K for 1,868 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 322 | 154 | $8.62 | $2,777 |
| 80053 Clinical Chemistry | 215 | 108 | $10.16 | $2,185 |
| 84481 Clinical Chemistry | 189 | 88 | $16.33 | $3,086 |
| 84439 Clinical Chemistry | 187 | 87 | $8.61 | $1,610 |
| 84443 Clinical Chemistry | 184 | 86 | $16.02 | $2,948 |
| 80061 Clinical Chemistry | 164 | 77 | $12.88 | $2,112 |
| 82570 Clinical Chemistry | 159 | 76 | $4.95 | $788 |
| 82043 Clinical Chemistry | 159 | 76 | $5.52 | $878 |
| 83036 Blood Count | 159 | 76 | $9.29 | $1,476 |
| 82306 Clinical Chemistry | 47 | 33 | $29.01 | $1,363 |
Medicare prescription drug claims, 2024
In 2024, the drug Tammara Bezanson prescribed most often to Medicare patients was Levothyroxine Sodium, with 657 prescriptions and refills. In total Tammara Bezanson wrote 4,071 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 657 | 1,854 | 206 | $6,307 |
| Rosuvastatin Calcium Generic | 200 | 562 | 75 | $2,686 |
| Metformin Hcl Generic | 200 | 575 | 86 | $1,141 |
| Farxiga Dapagliflozin Propanediol | 194 | 445 | 60 | $242K |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 153 | 390 | 61 | $88K |
| Atorvastatin Calcium Generic | 150 | 429 | 54 | $1,384 |
| Ozempic Semaglutide | 144 | 245 | 37 | $238K |
| Synthroid Levothyroxine Sodium | 135 | 360 | 38 | $12K |
| Janumet Sitagliptin Phos/Metformin Hcl | 120 | 295 | 45 | $156K |
| Januvia Sitagliptin Phosphate | 112 | 282 | 44 | $148K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 96 | 262 | 41 | $20K |
| Methimazole Generic | 85 | 250 | 31 | $604 |
| Lisinopril Generic | 85 | 243 | 34 | $811 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 83 | 192 | 34 | $42K |
| Mounjaro Tirzepatide | 79 | 90 | 12 | $99K |
Brand drugs: 2,126 claims; generic drugs: 1,748 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tammara Bezanson $786 ($786 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $138.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $138 |
| Corcept Therapeutics CORT | 5 | $90.96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $78.12 |
| Amgen Inc. AMGN | 2 | $62.33 |
| Antares Pharma, Inc. | 3 | $59.41 |
| Lilly USA, LLC LLY | 2 | $39.81 |
| Xeris Pharmaceuticals, Inc. | 2 | $38.5 |
| Sequel Med Tech, LLC | 2 | $36.23 |
| Averitas Pharma Inc. | 1 | $34.8 |
| Insulet Corporation PODD | 1 | $32.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.